-
1 Comment
Anhui Anke Biotechnology (Group) Co., Ltd is currently in a long term uptrend where the price is trading 6.1% above its 200 day moving average.
From a valuation standpoint, the stock is 23.6% more expensive than other stocks from the Healthcare sector with a price to sales ratio of 11.9.
Anhui Anke Biotechnology (Group) Co., Ltd's total revenue rose by 10.1% to $440M since the same quarter in the previous year.
Its net income has increased by 24.6% to $137M since the same quarter in the previous year.
Finally, its free cash flow grew by 44.7% to $51M since the same quarter in the previous year.
Based on the above factors, Anhui Anke Biotechnology (Group) Co., Ltd gets an overall score of 4/5.
| Sector | Healthcare |
|---|---|
| Industry | Biotechnology |
| CurrencyCode | CNY |
| ISIN | CNE100000GY2 |
| Exchange | SHE |
| Beta | 0.39 |
|---|---|
| Market Cap | 20B |
| PE Ratio | 27.56 |
| Target Price | 18.92 |
| Dividend Yield | 1.7% |
Anhui Anke Biotechnology (Group) Co., Ltd. develops, produces, and markets pharmaceutical products in China and internationally. The company offers recombinant human growth hormone for injection under the Ansomone name; and recombinant human interferon alpha 2b lyophilized powder, liquid, and prefilled syringe for injection, as well as recombinant human interferon alpha 2b cream, eye drop, and suppository under the Anterferon name. It also provides anti-sperm antibody, semen leukocyte peroxidase staining, one-time semen processing, sperm hypo-osmotic staining, sperm life detection, sperm staining detection, sperm acrosin detection, sperm DNA fragmentation staining, and leptin and immunohistochemical diagnostic kits. In addition, the company offers adhesive plasters, oral solutions, topical preparations, and ointments; peptide APIs; beauty care and anti-aging products; and synthetic drugs in the form of oral powders, dripping pills, and tablets and capsules. Further, it provides autosomal, sex chromosome, autosomal and sex chromosome combination, and other kits, as well as paternity testing set packages; tumor biological immunotherapy products; and DNA testing professional services. The company was founded in 2000 and is based in Hefei, China.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for 300009.SHE using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2024
